Little molecule makes big difference in bladder cancer metastasis

April 9, 2013

In order to kill, bladder cancer must metastasize, most commonly to the lung – what are the differences between bladder cancers that do and do not make this deadly transition? Research presented by the Director of the University of Colorado Cancer Center at the AACR Annual Meeting 2013 shows that one big difference is a little molecule known as hsa-miR-146a.

or mRNA carries gene blueprints to sites where the plans are read and made into proteins, and to a large degree microRNA or miRNA tells mRNA what to do. Theodorescu's work shows that in 256 samples of human bladder cancer, especially the tiny miRNA, hsa-miR-146a is overexpressed in the most . The molecule tells its mRNA partner to manufacture genes in a way that makes metastatic.

"Not only did we discover one specific molecule involved in bladder , but we discovered a host of miRNA and mRNA pairs that bear further study," says Dan Theodorescu, MD, PhD, director of the CU Cancer Center and the paper's senior author.

Consider this: researchers used to data-mine tumor genomes for mutated genes that could cause cancer. Then researchers discovered that even healthy genes turned on and off or over/under-expressed at unfortunate times could cause cancer and so started looking for mRNA causes of this mis-expression. And now researchers including Theodorescu and colleagues are exploring a layer deeper to discover how miRNA affects mRNA, which affects gene expression, which causes cancer.

"You dig deep enough into these causal chains and you start to learn basic things about this disease and its progression," Theodorescu says.

Related Stories

Team genetically sequences most common bladder cancer

August 11, 2011

In an article published online this week in Nature Genetics, a University of Colorado Cancer Center team in partnership with universities in China and Denmark reports the first genetic sequencing of urothelial (transitional) ...

Lack of oxygen in cancer cells leads to growth and metastasis

September 13, 2012

(Medical Xpress)—It seems as if a tumor deprived of oxygen would shrink. However, numerous studies have shown that tumor hypoxia, in which portions of the tumor have significantly low oxygen concentrations, is in fact linked ...

Recommended for you

New treatment options for a fatal leukemia

July 27, 2015

In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...

Exciting results from cancer immunoagent study

July 20, 2015

(Medical Xpress)—Cancer therapies have improved incrementally over the years, but cancer treatment largely remains analogous to forest fire suppression, in which the spread of fire is contained with deliberate controlled ...

Modified DNA building blocks are cancer's Achilles heel

July 22, 2015

In studying how cells recycle the building blocks of DNA, Ludwig Cancer Research scientists have discovered a potential therapeutic strategy for cancer. They found that normal cells have highly selective mechanisms to ensure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.